ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 140 filers reported holding ATARA BIOTHERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,480,000 | -8.1% | 1,000,000 | 0.0% | 7.58% | -33.6% |
Q2 2023 | $1,610,000 | -44.5% | 1,000,000 | 0.0% | 11.42% | -36.4% |
Q1 2023 | $2,900,000 | -11.6% | 1,000,000 | 0.0% | 17.94% | +63.8% |
Q4 2022 | $3,280,000 | -13.2% | 1,000,000 | 0.0% | 10.95% | +13.2% |
Q3 2022 | $3,780,000 | -51.5% | 1,000,000 | 0.0% | 9.67% | -23.8% |
Q2 2022 | $7,790,000 | -16.1% | 1,000,000 | 0.0% | 12.69% | +88.6% |
Q1 2022 | $9,290,000 | -41.1% | 1,000,000 | 0.0% | 6.73% | +4.0% |
Q4 2021 | $15,760,000 | -16.1% | 1,000,000 | -4.8% | 6.47% | +21.6% |
Q3 2021 | $18,795,000 | +20.9% | 1,050,000 | +5.0% | 5.32% | +24.3% |
Q2 2021 | $15,550,000 | +8.3% | 1,000,000 | 0.0% | 4.28% | -3.5% |
Q1 2021 | $14,360,000 | -26.8% | 1,000,000 | 0.0% | 4.44% | -19.5% |
Q4 2020 | $19,630,000 | +51.5% | 1,000,000 | 0.0% | 5.51% | +16.3% |
Q3 2020 | $12,960,000 | +11.2% | 1,000,000 | +25.0% | 4.74% | -11.9% |
Q2 2020 | $11,656,000 | +519.7% | 800,000 | +262.0% | 5.38% | +210.0% |
Q1 2020 | $1,881,000 | – | 221,000 | – | 1.74% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Antipodean Advisors LLC | 1,000,000 | $1,610,000 | 11.42% |
Redmile Group, LLC | 6,048,123 | $9,737,478 | 0.37% |
Baupost Group | 9,773,616 | $15,736 | 0.28% |
JOSH ARNOLD INVESTMENT CONSULTANT, LLC | 170,000 | $273,700 | 0.27% |
MAVERICK CAPITAL LTD | 6,290,713 | $10,128,048 | 0.22% |
683 Capital Management, LLC | 1,000,000 | $1,610,000 | 0.12% |
WASATCH ADVISORS LP | 8,283,981 | $13,337,209 | 0.08% |
PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 525,000 | $845,250 | 0.08% |
STALEY CAPITAL ADVISERS INC | 750,000 | $1,207,500 | 0.06% |
XTX Topco Ltd | 136,841 | $220,314 | 0.04% |